Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome

Keyphrases

• Preeclampsia 100%
• Antiphospholipid Syndrome 100%
• Atorvastatin 100%
• Obstetric Complications 100%
• Selective Intrauterine Growth Restriction (sIUGR) 100%
• Statins 66%
• Pathophysiology 33%
• Study Support 33%
• High Risk 33%
• Standard of Care 33%
• Pregnant Women 33%
• Fetomaternal Outcome 33%
• Randomized Clinical Trial 33%
• With Woman 33%
• Preeclampsia Prevention 33%
• Low-dose Aspirin 33%
• Low-dose Heparin 33%
• Observational Trial 33%
• Atherosclerotic Cardiovascular Disease (ASCVD) 33%
• Fetal-neonatal Outcome 33%

Medicine and Dentistry

• Pre-Eclampsia 100%
• Antiphospholipid Syndrome 100%
• Pravastatin 100%
• Intrauterine Growth Retardation 75%
• Statin 50%
• Pathophysiology 25%
• Acetylsalicylic Acid 25%
• Clinical Study 25%
• Randomized Clinical Trial 25%
• Low Drug Dose 25%
• Heparin 25%